Sign in
4

Changes in Ownership

UNITED THERAPEUTICS Corp Filed Acc 0001106578-26-000109

Chairperson & CEO sold 9,500 shares at an average $522.37 ($4,962,488)

  • Chairperson & CEO acquired 9,500 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

ROTHBLATT MARTINE A · Chairperson & CEO

Table I: Non-derivative

9 lines
Date Transaction Shares Price Value Owned after D/I
2026-07-29 Exercise or conversion : show line 1 in the form 10b5-1 +9,500 $135.42 $1,286,490 333,943 I
2026-07-29 Sale : show line 2 in the form 10b5-1 −798 $518.25 $413,565 333,145 I
2026-07-29 Sale : show line 3 in the form 10b5-1 −1,112 $519.29 $577,453 332,033 I
2026-07-29 Sale : show line 4 in the form 10b5-1 −900 $520.40 $468,364 331,133 I
2026-07-29 Sale : show line 5 in the form 10b5-1 −1,270 $521.32 $662,078 329,863 I
2026-07-29 Sale : show line 6 in the form 10b5-1 −880 $522.51 $459,813 328,983 I
2026-07-29 Sale : show line 7 in the form 10b5-1 −1,318 $523.63 $690,138 327,665 I
2026-07-29 Sale : show line 8 in the form 10b5-1 −1,982 $524.47 $1,039,503 325,683 I
2026-07-29 Sale : show line 9 in the form 10b5-1 −1,240 $525.46 $651,575 324,443 I
Open-market sales · 9,500 sh · avg $522.37 · $4,962,488

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-07-29 Exercise or conversion : show line 10 in the form 10b5-1 Stock Option −9,500 246,410 I
Loading xslF345X06/primarydocument.xml…